Stefan Kubicek

Stefan Kubicek

Chemical Biology and Epigenetics

Funding

Chemical ARX degraders

Breakthrough T1D "2-INO-2024-1537-A-N"

Stefan Kubicek

Breakthrough FY24 Innovative Award (INO)
Duration 2024 - 2025

Breakthrough T1D (formerly JDRF)

Targeting mannosylation for regenerating beta cell mass

Breakthrough T1D "2-SRA-2023-1302-S-B"

Stefan Kubicek

Breakthrough T1D Strategic Research Agreement Single Project
Duration 2022 - 2025

Breakthrough T1D (formerly JDRF)

CD Laboratory for Chemical Epigenetics and Antiinfectives

CD Laboratory for Chemical Epigenetics and Antiinfectives

Stefan Kubicek Christian

Doppler Laboratories Duration 2013 - 2019

CDG

Translating Tudor domain splicing inhibitors for oncological applications

ERC Proof of Concept Grant "ONCO-SPLICE"

Stefan Kubicek

ERC-2024-POC
Duration 2024 - 2026

Link to project

Point of Contact: Pinpointing Small Molecule-Protein Binding

FWF 1000 Ideen TAI2640624

Stefan Kubicek

FWF 1000 Ideen
Duration 2025 - 2027

FWF

Resetting the Epigenetic Status of the DM1Locus

FWF International I4768 "Resetting the Epigenetic Status of the DM1Locus"

Stefan Kubicek

FWF International Programme
Duration 2021 - 2024

FWF

Visual Proteomics for studying subcellular protein dynamics

FWF Stand-Alone PAT1340623

Stefan Kubicek

FWF Stand-Alone Program
Duration 2024 - 2027

FWF

Innovative chemistry library to probe biology

OeAW Innovation Fund Project 2023

Stefan Kubicek

OeAW Innovation Fund
Duration 2023 - 2023

ÖAW

Mechanistic target elucidation by systematic stochastic tagging of antiproliferative compounds

WWTF LS21 - 010 "Mechanistic target elucidation by systematic stochastic tagging of antiproliferative compounds"

Stefan Kubicek

WWTF LS21 Life Sciences Call
Duration 2022 - 2025

WWTF